Amryt Pharma Competitors and Similar CompaniesClear all

Amryt Pharma's competitors and similar companies include Cadila Pharmaceuticals, Genentech, UCB and Cipla.

	Amryt Pharma Amryt Pharma is a specialty pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases.	Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date 2004	Founding Date 1951	Founding Date 1976	Founding Date 1928	Founding Date 1935
Type	Type Subsidiary	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Greater London, GB HQ Niefern öschelbronn, DE Dublin, IE Dublin, IE London, GB Boston, US Boston, US	Locations Bavla, IN HQ Akaki, ET Dholka, IN Chiyoda City, JP Nairobi, KE Moskva, RU Ascot, GB see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees 182	Employees 8,5201% increase	Employees 18,077	Employees 9,052	Employees 27,764
Financial
Revenue (est.)	Revenue (est.) $222.5m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)
Cost of goods	Cost of goods $52.8m (FY, 2021)	Cost of goods N/A	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)	Cost of goods ₹95.5b (FY, 2026)
Gross profit	Gross profit $169.8m (FY, 2021)	Gross profit N/A	Gross profit N/A	Gross profit €7.2b (FY, 2025)	Gross profit ₹195b (FY, 2026)
Net income	Net income $1m (FY, 2021)	Net income N/A	Net income N/A	Net income €1.6b (FY, 2025)	Net income ₹38.7b (FY, 2026)